The views of people with a lived experience of deafness and the general public regarding genetic testing for deafness in the reproductive setting: A systematic review.

ELSEVIER SCIENCE INC 2022-09

Freeman, L
Righetti, S
Delatycki, MB
Scully, JL
Kirk, EP

PURPOSE: Genes associated with nonsyndromic hearing loss are commonly included in reproductive carrier screening panels, which are now routinely offered in preconception and prenatal care in many countries. However, there is debate whether hearing loss should be considered a medical condition appropriate for screening. This systematic review assessed research on opinions of those with a lived experience of deafness and the general public regarding genetic testing for deafness in the reproductive setting. METHODS: Search of 5 online databases yielded 423 articles, 20 of which met inclusion criteria. We assessed the quality of each study, extracted data, and performed thematic analysis on qualitative studies. RESULTS: Most studies indicated interest in the use of prenatal diagnosis for deafness. However, there were mixed views, and sometimes strongly held views, expressed regarding the reproductive options that should be available to those with an increased chance of having a child with deafness. Studies were small, from a limited number of countries, and most were too old to include views regarding preimplantation genetic testing. CONCLUSION: There is a broad range of views regarding the use of reproductive options for deafness. Further research is essential to explore the benefits and harms of including nonsyndromic hearing loss genes in carrier screening.

0604 Genetics, 1103 Clinical Sciences; Journal Article

LT1 oai:opus.lib.uts.edu.au:10453/170567
Genet Med, 2022, 24, (9), pp. 1803-1813
1098-3600
1530-0366
1382618362

UNIV OF TECH, SYDNEY
From OAIster®, provided by the OCLC Cooperative.

edsoai.on1382618362